Millet Innovation Sa operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Millet Innovation Sa with three other
companies in this sector in France:
Les Trois Chenes
(2016
sales of 27.34 million Euro [US$33.39 million]
),
Diaxonhit SA
(27.72 million Euro [US$33.84 million]
of which 100%
was Genetic R&D), and
Dbv Technologies
(9.08 million Euro [US$11.09 million]
of which 100%
was Research & Development).
Sales Analysis.
Millet Innovation Sa reported sales of 23.16 million Euro (US$28.28 million)
for the
year ending
December of 2016.
This
represents
an
increase of 6.2%
versus 2015, when the company's sales were 21.81 million Euro.
Sales at Millet Innovation Sa have increased during each of the previous five years
(and since 2011, sales have increased a total of 43%).
Sales of Pharmacies and Pharmaceutical Wholesale De saw an increase
of
7.0% in 2016, from
20.17 million Euro to 21.59 million Euro.
Not all segments of Millet Innovation Sa experienced an increase in sales in 2016:
sales of Other fell 57.5% to 46,327.63 Euro.
(However, this segment's sales were only a very small portion of the company's overall sales).
Millet Innovation Sa also experienced decreases in sales in
Correspondance Sales (down 5.9% to 1.44 million Euro)
.